Elaine Heron

Applera Corp. manufactures medical instruments

Fluxion Biosciences, Inc. conducts clinical research for early cancer detection and patient monitoring. It offers live cell analysis, automated patch clamping, and circulating tumor cell analysis. The company was founded by Michelle Khine, Cristian Ionescu-Zanetti, and Michael Schwartz in 2006 and is headquartered in Alameda, CA.

Labcyte, Inc. operates as a biotechnology tools company that manufactures and markets echo liquid handling systems. It offers liquid handling, automation and consumables. The company was founded by Richard Nathan Ellson and Mark D. Fischer-Colbrie and A. Mark Bramwell in October 2003 and is headquartered in Sunnyvale, CA.

Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.

Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA.

Vala Sciences, Inc. provides a platform for in vitro drug screening. The private company is based in San Diego. The American company's technology is used by premier research institutions, including the Broad Institute of MIT and Harvard. Vala's platform uses proprietary fully automated video cytometry to simultaneously record and measure the effects of drug candidates on human hipscs loaded into well plates.

Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA.

Dropworks, Inc. develops automated platform for performing biological assays. The company was founded by Chris Perkins and Andrew Larsen and is headquartered in Phoenix, AZ.

Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA.

Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.

Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA.